Abstract
We have investigated whether the raf-1 kinase, a downstream mediator of both receptor tyrosine kinase and protein kinase C signalling, is activated by estrogen (E2) in an estrogen receptor positive human breast cancer cell line. Autophosphorylation of raf-1 kinase was studied after treatment of MCF-7 cells with E2. E2-deprived cells contained low levels of raf-1 kinase activity. Treatment of cells for 1 min with E2 resulted in raf-1 autophosphorylation which was maximal within 5 min. Western blot analysis showed that raf-1 undergoes an electrophoretic mobility shift following E2 treatment. Egr-1 is a zinc finger-containing transcription factor which is expressed in association with raf-1 activation. Untreated MCF-7 cells expressed low levels of Egr-1 while E2 treatment resulted in an induction of egr-1 mRNA expression. These kinetics followed closely behind the E2 induction of c-myc mRNA. Egr-1 protein was similarly low in E2-deprived MCF-7 cells and was transiently increased following E2 treatment. Several studies have suggested that kinase activity may play a role in estrogen receptor (ER) activation. While activated v-raf failed to augment ER activation of transcription in transient transfection assays, a dominant negative mutant of raf-1 inhibited E2-induced transcription by 50% primarily as a result of increased baseline levels of E2 independent transcription. The results show that E2 can induce raf-1 kinase activity in MCF-7 breast cancer cells associated with the expression of an early growth response gene and modulation of ER signalling.
Similar content being viewed by others
References
Beato M, Herrlich P, Schutz G: Steroid hormones: Many actors in search of a plot. Cell 83: 851–857, 1995
Davidson NE, Prestigiacomo LJ, Hahm HA: Induction of jun gene family members by transforming growth factor α ?but not 17‐β ?estradiol in human breast cancer cells Cancer Res 53: 291–297, 1993
Wilding G, Lippman ME, Gelmann EP: Effects of steroid hormones and peptide growth factors on protooncogene c‐fos expression in human breast cancer cells. Cancer Res 48: 802–805, 1988
Weisz A, Cicatiello L, Persico E, Scalona M, Bresciani F: Estrogen stimulates transcription of c‐jun protooncogene. Mol Endocrinol 4: 1041–1050, 1990
Webb DX, Moulton BC, Khan SA; Estrogen induced expression of the c‐jun proto‐oncogene in the immature and mature rat uterus. Biochem Biophys Res Comm 168: 721–726, 1990
Travers MT, Knowler JT: Oestrogen‐induced expression of oncogenes in the immature rat uterus. FEBS Lett 211: 27–30, 1987
Dubik D, Shiu RPC: Transcriptional regulation of c‐myc oncogene expression by estrogen in hormone‐responsive human breast cancer cells. J Biol Chem 263: 12705–12708, 1988
Ignar‐Trowbridge DM, Hughes AR, Putney JW, McLachlan JA, Korach KS: Diethylstilbesterol stimulates persistent phosphytidylinositol lipid turnover by an estrogen receptor‐mediated mechanism in immature mouse uterus. Endocrinol 129: 2423–2430, 1991
Grove RI, Korach KS: Estrogen stimulation of phosphtidylinositol metabolism in mouse uterine tissue. Endocrinol 121: 1083–1088, 1987
Morley P, Whitfield JF, Vanderhyden BC, Tsang BK, Schwartz JL: A new, nongenomic estrogen action: the rapid release of intracellular calcium. Endocrinology 131: 1305–1312
Ali S, Metzger D, Bornert J‐M, Chambon P: Modulation of transcriptional activation by ligand‐dependent phosphorylation of the human estrogen receptor A/B region. EMBO J 12: 1153–1160, 1993
Le Goff P, Montano MM, Schodin DJ, Katzenellenbogen BS: Phosphorylation of the human estrogen receptor: Identification of hormone‐regulated sites and examination of the their influence on transcriptional activity. J Biol Chem 269: 4458–4466, 1994
Roberts TM: Cell biology: A signal chain of events. Nature 360: 534–602, 1992
Kizaka‐Kondoh S, Sato K, Tamura K, Nojima H, Okayama H: Raf‐1 protein kinase is an integral component of the oncogenic signal cascade shared by epidermal growth factor and platelet‐derived growth factor. Mol Cell Biol 12: 5078–5086, 1992
Rapp UR: Role of Raf‐1 serine threonine protein kinase in growth factor signal transduction. Oncogene 6: 495–500, 1991
Kolch W, Heidecker G, Kochs G, Hummel R, Vahidi H, Mischak H, Finkenzeller G, Marme D, Rapp UR: Protein kinase Cα ?activates RAF‐1 by direct phosphorylation. Nature 364: 249–252, 1993
Cai H, Erhardt P, Troppmair J, Diaz‐Meco MT, Sithanandam G, Rapp UR, Moscat J, Cooper GM: Hydrolysis of phosphatidylcholine couples ras to activation of raf protein kinase during mitogenic signal transduction. Mol Cell Biol 13: 7645–7651, 1993
Howe LR, Leevers SJ, Gomez N, Nakieiny S, Cohen P, Marshall CJ: Activation of the MAP kinase pathway by the protein kinase raf. Cell 71: 335–342, 1992
Sukhatme VP, Cao X, Chang LC, Tsai‐Morris C‐W, Stamenkovich D, Ferreira PCP, Cohen DR, Edwards SA, Shows TB, Curran T, Le Beau MM, Adamson ED: A zinc finger‐encodig gene coregulated with c‐fos during growth and differentiation, and after cellular depolarization Cell 53: 37–43, 1998
Chen C, Okayama H: A high efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 7: 2745–2752, 1987
Sleigh MJ: A non‐chromatographic assay for the chloramphenicol acetyltransferase gene in eukaryotic cells. 156: 251–256, 1986
Auffray C, Rougeon F: Purification of mouse immunoglobulin heavy chain messenger RNAs from total myeloma tumor RNA. Eur J Biochem 107: 303–314, 1980
Maniatis T, Fritsch EF, Sambrook J: Molecular cloning: A laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA, 1982
Lemaire P, Revelent O, Bravo R, Charnay P: Two genes encoding potential transcription factors with identical DNA‐binding domains are activated by growth factors in cultured cells. Proc Natl Acad Sci USA 85: 4691–4695, 1988
Sukhatme VP: Early transcriptional events in cell growth: The Egr family. J Am Soc Nephrol 1: 859–866, 1990
Rim M, Qureshi SA, Guis D, Nho D, Sukhatme VP, Foster DA: Evidence that activation of the Egr‐1 promoter by v‐Raf involves serum response elements. Oncogene 7: 2065–2068, 1992
Musgrove EA, Sutherland RL: Steroids, growth factors and cell cycle controls in breast cancer. In: M.E. Lippman and R.B. Dickson (eds). Regulatory Mechanisms in Breast Cancer. Kluwer Academic Publishers, Boston, 1991, pp 305–331
Moinar G, Crozat A, Pardee A: The immediate early gene Egr‐1 regulates the activity of the thymidine kinase promoter at the G0‐G1 transition of the cell cycle. Mol Cell Biol 14: 5242–5248, 1994
Aronica SM, Katzenellenbogen BS: Stimulation of estrogen receptormediated transcription and alteration of the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate and insulin‐like growth factor. Mol Endocrinol 7: 743–752, 1993
Cho H, Katzenellenbogen BS: Synergistic activation of estrogen receptor mediated transcription by estradiol and protein kinase activators. Mol Endocrinol 7: 441–452, 1993
Rapp UR, Goldsborough MD, Mark GE, Bonner TI, Groffen J, Reynolds FH, Stephenson JR: Structure and biological activity of v‐raf, a unique oncogene transduced by a retrovirus. Proc Natl Acad Sci USA 80: 4218–4222, 1983
MacNicol AM, Muslin AA, Williams LT: Raf‐1 kinase is essential for early Xenopus development and mediates the induction of mesoderm by FGF. Cell 73: 571–585, 1993
Freter CE, Lippman ME, Cheville A, Zinn S, Gelmann EP: Alterations in phosphoinositide metabolism associated with 17β‐estradiol and growth factor treatment of MCF‐7 breast cancer cells. Mol Endocrinol 2: 159–216, 1988
Lissoos T, Beno DWA, Davies BH: 1,25‐dihydroxyvitamin D3 activates Raf‐1 kinase and Raf perinuclear translocation via a protein kinase C‐dependent pathway. J Biol Chem 268: 25132–25138, 1993
Muslin AA, MacNicol AM, Williams LT: Raf‐1 protein kinase is important for progesterone‐induced Xenopus oocyte maturation and acts downstream of mos. Mol Cell Biol 13: 4197–4202, 1993
Samuels ML, Weber MA, Bishop JM, McMahon M: Conditional transformation of cells and rapid activation of the mitogen‐activated protein kinase cascade by an estradiol‐dependent human raf‐1 protein kinase. Mol Cell Biol 13: 6241–6252, 1993
Suva LJ, Harm SC, Russell MG, Thiede MA: In vivo regulation of Zif268 messenger RNA expression by 17β‐estradiol in the rat uterus. Mol Endocrinol 5: 829–835, 1991
Ignar‐Trowbridge DM, Teng CT, Ross KA, Parker MG, Korach KS, Mclachlan JA: Peptide growth factors elicit estrogen receptor‐dependent transcriptional activation of an estrogen response element. Mol Endocrinol 7: 992–998, 1993
Migliaccio S, Wetsel WC, Fox WM, Washburn TF, Korach KS: Endogenous protein kinase‐C activation in osteoblast‐like cells modulates responsiveness to estrogen and estrogen receptor levels. Mol Endocrinol 7: 1133–1143, 1993
Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, Masuhige S, Gotoh Y, Nishida E, Kawashima H, Metzger D, Chambon P: Activation of the estrogen receptor through phosphorylation by mitogen‐activated protein kinase. Science 270: 1491–1494, 1995
Kuo WL, Abe M, Rhee J, Eves EM, McCarthy SA, Templeton DJ, McMahon M, Rosner MR: Raf, but not MEK or ERK, is sufficient for differentiation of hippocampal neuronal cells. Mol Cell Biol 16: 1458–1470, 1996
Lenormand P, McMahon M, Pouyssegur J: Oncogenic Raf‐1 activates p70 S6 kinase via a mitogen‐activated protein kinase‐independent pathway. J Biol Chem 271: 15762–15768, 1996
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pratt, M.C., Satkunaratnam, A. & Novosad, D.M. Estrogen activates raf-1 kinase and induces expression of Egr-1 in MCF-7 breast cancer cells. Mol Cell Biochem 189, 119–125 (1998). https://doi.org/10.1023/A:1006827015320
Issue Date:
DOI: https://doi.org/10.1023/A:1006827015320